Source:http://linkedlifedata.com/resource/pubmed/id/21370966
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0015672,
umls-concept:C0028754,
umls-concept:C0034656,
umls-concept:C0056077,
umls-concept:C0311400,
umls-concept:C0549193,
umls-concept:C0599949,
umls-concept:C0681850,
umls-concept:C0681867,
umls-concept:C1280500,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-29
|
pubmed:abstractText |
This study investigated the effects of coenzyme Q(10) supplementation on metabolic parameters, inflammatory markers, arterial stiffness, and fatigue in obese subjects. We performed a randomized, double-blind, placebo-controlled, single-center study on 51 obese subjects with a body mass index (BMI) of ?25?kg/m(2). Subjects were randomized into either a coenzyme Q(10) (200?mg/day) group (n?=?26, BMI?=?27.9?±?2.3?kg/m(2), age?=?42.7?±?11.3 years) or a placebo group (n?=?25, BMI?=?26.8?±?2.8?kg/m(2), age?=?41.3?±?11.2 years) for a 12-week study. We collected anthropometric measurements, blood for laboratory testing, brachial-ankle pulse wave velocity (baPWV) as an indicator of arterial stiffness, and responses to a fatigue severity scale (FSS) questionnaire at the initial (0 week) and final (12 weeks) visits. A total of 36 subjects successfully completed the study protocol. Serum coenzyme Q(10) levels increased significantly from 0.65?±?0.27??g/mL to 1.20?±?0.38??g/mL in the coenzyme Q(10) group (P?<?.001). Oral administration of coenzyme Q(10) did not significantly affect lipid profiles, oxidative and inflammatory markers [including lipoprotein (a), oxidized low-density lipoprotein level, C-reactive protein, and white blood cell count], or baPWV. The mean FSS score decreased significantly from 40.1 to 33.1 in the coenzyme Q(10) group (P?=?.017), but no significant change was seen in the placebo group (P?=?.464). However, the extents of the change in mean FSS score between the placebo and coenzyme Q(10) groups were not significantly different (P?=?.287). In conclusion, we found no evidence that coenzyme Q(10) affects fatigue index, arterial stiffness, metabolic parameters, or inflammatory markers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquinone,
http://linkedlifedata.com/resource/pubmed/chemical/coenzyme Q10
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1557-7600
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
386-90
|
pubmed:meshHeading |
pubmed-meshheading:21370966-Administration, Oral,
pubmed-meshheading:21370966-Adult,
pubmed-meshheading:21370966-Ankle Brachial Index,
pubmed-meshheading:21370966-Arteries,
pubmed-meshheading:21370966-Blood Glucose,
pubmed-meshheading:21370966-Body Mass Index,
pubmed-meshheading:21370966-C-Reactive Protein,
pubmed-meshheading:21370966-Cholesterol, LDL,
pubmed-meshheading:21370966-Double-Blind Method,
pubmed-meshheading:21370966-Fatigue,
pubmed-meshheading:21370966-Female,
pubmed-meshheading:21370966-Humans,
pubmed-meshheading:21370966-Male,
pubmed-meshheading:21370966-Middle Aged,
pubmed-meshheading:21370966-Obesity,
pubmed-meshheading:21370966-Questionnaires,
pubmed-meshheading:21370966-Ubiquinone,
pubmed-meshheading:21370966-Vascular Resistance
|
pubmed:year |
2011
|
pubmed:articleTitle |
Effects of coenzyme Q10 on arterial stiffness, metabolic parameters, and fatigue in obese subjects: a double-blind randomized controlled study.
|
pubmed:affiliation |
Department of Family Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|